Veerhealth Care Annual General Meeting
Veerhealth Care Ltd issued a corrigendum to its 34th AGM notice, revising the scheduled meeting time to 04:00 P.M. on 23rd September 2026.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
31 announcements with these filters
Veerhealth Care Ltd issued a corrigendum to its 34th AGM notice, revising the scheduled meeting time to 04:00 P.M. on 23rd September 2026.
Veerhealth Care Ltd received its first purchase order for oral care products worth ₹0.10 Crore. The contract is to be executed within 45 days.
Veerhealth Care Ltd secured a monthly repeat order worth ₹4.36 Crore from a leading FMCG company for skin care products. The order will be executed within 45 days.
Veerhealth Care Ltd has received an order from an FMCG company for skincare products. The order is valued at ₹4.37 Crore and requires 45-day execution.
Veerhealth Care Ltd has published its notice of the 34th Annual General Meeting scheduled for September 23, 2026. The meeting will be conducted via video conferencing.
Veerhealth Care reported Q1FY27 total revenue of ₹25.09 Crore, with EBITDA of ₹2.07 Crore and PAT of ₹1.23 Crore. The company also highlighted its recent USFDA clearance.
Veerhealth Care Limited announced the resignation of Ashita Chittora as Company Secretary and the appointment of Ruchi as the new Company Secretary, effective August 13, 2026.
Veerhealth Care Ltd reported revenue from operations of ₹24.9 Cr (+453.3% YoY) and net profit of ₹1.2 Cr (+500.0% YoY) for Q1 FY27.
Veerhealth Care Ltd secured a repeat order worth ₹5.27 crore from a major FMCG client, alongside a ₹0.16 crore sample order from Sudan.
Veerhealth Care Ltd will hold a Board of Directors meeting on August 13, 2026, to approve the unaudited financial results for the quarter ended June 30, 2026.
Veerhealth Care Ltd received an order for skincare products from an FMCG company valued at ₹5.27 Crore. The order will be executed within 45 days.
Veerhealth Care Ltd secured an export order worth ₹0.1574 Crore from a Sudan-based buyer to supply Gripe Water. This marks the company's first entry into the market.
Veerhealth Care Ltd secured a ₹0.764 Crore contract manufacturing order for skincare products. The order will be executed within 45 days.
Veerhealth Care Ltd filed its quarterly shareholding pattern for the period ending June 30, 2026. The document details equity distribution among promoters and public shareholders.
Veerhealth Care secured a Rs. 1.11 Crore order for haircare and oral care products. The domestic contract will be executed within 45 days.
Veerhealth Care Ltd disclosed allotment of warrants to promoters under SAST Reg 29(2). Post-allotment, promoter holding rose to 33.84% from 28.07%.
Veerhealth Care approved preferential allotment of 1 crore warrants at Rs.20.25 each. The move raises capital and adjusts equity structure for promoters and non-promoters.
Veerhealth Care (ayuVeer) reported FY26 revenue of ₹32.48 Cr and PAT of ₹0.54 Cr. Strategy focuses on 'Local to Global' expansion, USFDA-cleared OTC exports, and backward integration via Veer Plast.
Veerhealth Care Ltd secured a ₹3.6 Crore skincare product order from a domestic FMCG major. The contract requires execution within 45 days.
Veerhealth Care reported ₹33.29 Crore Total Income for FY26, achieving 86% YoY growth. Management targets ₹100 Crore revenue within 24 months through expanded global and e-commerce presence.
Veerhealth Care Ltd reported revenue from operations of ₹16.8 Cr (+200.0% YoY) and a net loss of ₹0.4 Cr for Q4 FY26.
Veerhealth Care reported annual revenue of ₹33.29 Crore for FY26. The Board has not recommended any dividend to conserve internal corporate resources.
Veerhealth Care Ltd submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report confirms full compliance with SEBI regulations with no deviations.
Veerhealth Care scheduled a board meeting for May 30, 2026, to approve audited FY2026 results. The board will also consider recommending a dividend to shareholders.
Veerhealth Care secured a ₹2.45 Crore repeat order from a leading Indian FMCG firm. The contract involves supplying face care products within 45 days.
Veerhealth Care Ltd announced the approval of a special resolution via postal ballot for the issuance of up to 1,00,00,000 fully convertible warrants. The resolution, involving both promoter and non-promoter categories, passed with requisite majority. Voting concluded on April 30, 2026, with the scrutinizer's report issued on May 1, 2026.
Veerhealth Care Ltd received a repeat order from a New York-based company for body care products valued at approximately ₹1.43 Crore. The international contract is to be executed within 45 days. This order represents significant growth potential and an opportunity to increase turnover in the personal care segment.
Veerhealth Care Ltd received a ₹6.16 Crore order from a leading Indian FMCG company for face care products. The order is to be executed within 45 days. This contract represents a significant growth opportunity for the company's skincare segment and is expected to boost overall turnover.
Veerhealth Care Ltd issued a corrigendum to its postal ballot notice regarding a ₹20.25 Crore preferential issuance of convertible warrants. The update includes additional disclosures about promoter intent and corrected shareholding patterns. Warrants are exercisable within 18 months at ₹20.25 each, supporting manufacturing capacity expansion.
Veerhealth Care Ltd received an export order worth ₹1.5 Crore from a New York-based company for body care products. The contract is to be executed within 45 days on an FOB Nhava Seva basis. This international order represents a significant growth opportunity for the company's turnover.